Childhood Cancer Research


Too many types of childhood cancer still have no known cure or treatment. In 2018, more than 15,000 children under age 19 will be diagnosed with cancer. 

We must ensure that researchers have the essential tools to fight childhood cancer and make sure children with cancer not only survive, but thrive. 


Over 15,000 U.S. children under age 19 will be diagnosed with cancer in 2018.

Take Action

childhood cancer patient

Ask Congress to Improve the Quality of Life for Kids Fighting Cancer

Ask your member of Congress to cosponsor and pass PCHETA this Congress. By supporting PCHETA, they can improve the quality of life for kids and patients fighting cancer.

Latest Updates

Cancer Candor Blog
August 30, 2019
Related States: 
New Mexico

We’re proud to join the cancer community this September in recognition of Childhood Cancer Awareness Month and will continue to focus our advocacy efforts year-round to improve the diagnosis, treatment and quality of life for childhood cancer patients and survivors.

Cancer Candor Blog
March 28, 2019

Mariah Forster Olson, an ACS CAN Ambassador Constituent Team Lead (ACT Lead), traveled to Washington, D.C. this week to share her story as a childhood cancer survivor and to advocate on behalf of other patients and survivors during the 2019 Childhood Cancer Action Days.

March 27, 2019

Washington, D.C. – Advocates from the American Cancer Society Cancer Action Network (ACS CAN) joined more than 200 other childhood cancer patients, survivors, caretakers and family members on Capitol Hill today for the Alliance for Childhood Cancer’s eighth annual Childhood Cancer Action Day. This year, participants will ask their congressional

March 26, 2019
New Mexico

SANTA FE, N.M. -- Santa Fe residents and American Cancer Society Cancer Action Network (ACS CAN) volunteers Dr. Janis Gonzales and Liesl Gonzales travel to Washington, D.C., today to share the story of their daughter and sister, urge lawmakers to fully fund the bipartisan Childhood Cancer Survivorship, Treatment, Access and

Childhood Cancer Research Resources

Research has improved treatments and boosted survival in some types of pediatric cancer, but treatment toxicities still can cause significant suffering that continues into adulthood and can last a lifetime.

This report examines the drug development landscape for childhood cancer, identifying scientific, logistical, economic and ethical challenges that are unique to pediatric cancer drug development.